XML 28 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Mar. 28, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name ProKidney Corp    
Entity Central Index Key 0001850270    
Entity File Number 001-40560    
Entity Tax Identification Number 98-1586514    
Entity Incorporation, State or Country Code E9    
Entity Address, Address Line One 2000 Frontis Plaza Blvd    
Entity Address, Address Line Two uite 250    
Entity Address, City or Town Winston-Salem    
Entity Address, State or Province NC    
Entity Address, Postal Zip Code 27103    
City Area Code 336    
Local Phone Number 999-7028    
Document Transition Report false    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Shell Company false    
Entity Small Business true    
Entity Public Float     $ 248,750,000
Entity Emerging Growth Company true    
ICFR Auditor Attestation Flag false    
Entity Ex Transition Period false    
Title of 12(b) Security Class A ordinary shares, $0.0001 par value per share    
Trading Symbol PROK    
Security Exchange Name NASDAQ    
Documents Incorporated by Reference [Text Block]

If the Registrant’s Definitive Proxy Statement relating to the 2023 Annual Meeting of Shareholders (the “Proxy Statement”) is filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, then portions of the Proxy Statement will be incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed within such 120-day period, then the Registrant will file an amendment to this Annual Report within such 120-day period that will contain the information required to be included or incorporated by reference into Part III of this Annual Report.

    
Auditor Name Ernst & Young LLP    
Auditor Firm ID 42    
Auditor Location Raleigh, North Carolina, United States    
Common Class A [Member]      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   61,540,231  
Common Class B [Member]      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   173,381,731